183 related articles for article (PubMed ID: 33050526)
1. Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells.
Egorova A; Selutin A; Maretina M; Selkov S; Baranov V; Kiselev A
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33050526
[TBL] [Abstract][Full Text] [Related]
2. Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma.
Egorova A; Shtykalova S; Selutin A; Shved N; Maretina M; Selkov S; Baranov V; Kiselev A
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33540912
[TBL] [Abstract][Full Text] [Related]
3. Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells.
Egorova A; Selutin A; Maretina M; Selkov S; Kiselev A
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500454
[TBL] [Abstract][Full Text] [Related]
4. iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis.
Egorova A; Petrosyan M; Maretina M; Bazian E; Krylova I; Baranov V; Kiselev A
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631322
[TBL] [Abstract][Full Text] [Related]
5. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Nanoparticles as a Component of Peptide-Based DNA Delivery System for Suicide Gene Therapy of Uterine Leiomyoma.
Shtykalova S; Egorova A; Maretina M; Baranov V; Kiselev A
Bioengineering (Basel); 2022 Mar; 9(3):. PubMed ID: 35324801
[TBL] [Abstract][Full Text] [Related]
7. Highly branched HK peptides are effective carriers of siRNA.
Leng Q; Scaria P; Zhu J; Ambulos N; Campbell P; Mixson AJ
J Gene Med; 2005 Jul; 7(7):977-86. PubMed ID: 15772938
[TBL] [Abstract][Full Text] [Related]
8. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.
Egorova AA; Maretina MA; Kiselev AV
Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995
[TBL] [Abstract][Full Text] [Related]
9. iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma.
Liu Q; Dai G; Wu Y; Zhang M; Yang M; Wang X; Song M; Li X; Xia R; Wu Z
Front Oncol; 2022; 12():822805. PubMed ID: 35982974
[TBL] [Abstract][Full Text] [Related]
10. Development of a receptor-targeted gene delivery system using CXCR4 ligand-conjugated cross-linking peptides.
Egorova A; Bogacheva M; Shubina A; Baranov V; Kiselev A
J Gene Med; 2014; 16(11-12):336-51. PubMed ID: 25382058
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes.
Egorova AA; Shtykalova SV; Maretina MA; Sokolov DI; Selkov SA; Baranov VS; Kiselev AV
Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31174285
[TBL] [Abstract][Full Text] [Related]
12. Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells.
Egorova A; Shtykalova S; Maretina M; Selutin A; Shved N; Deviatkin D; Selkov S; Baranov V; Kiselev A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163086
[TBL] [Abstract][Full Text] [Related]
13. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
14. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
15. iRGD mediated pH-responsive mesoporous silica enhances drug accumulation in tumors.
Wang X; Zhao Y; Yan M; Liang X; Zhao N; Lu T
Eur J Pharm Sci; 2024 Apr; 195():106725. PubMed ID: 38346565
[TBL] [Abstract][Full Text] [Related]
16. Linear short histidine and cysteine modified arginine peptides constitute a potential class of DNA delivery agents.
Mann A; Shukla V; Khanduri R; Dabral S; Singh H; Ganguli M
Mol Pharm; 2014 Mar; 11(3):683-96. PubMed ID: 24476132
[TBL] [Abstract][Full Text] [Related]
17. Arginine-rich cross-linking peptides with different SV40 nuclear localization signal content as vectors for intranuclear DNA delivery.
Bogacheva M; Egorova A; Slita A; Maretina M; Baranov V; Kiselev A
Bioorg Med Chem Lett; 2017 Nov; 27(21):4781-4785. PubMed ID: 29017784
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated delivery of therapeutic RNA by peptide functionalized curdlan nanoparticles.
Ganbold T; Han S; Hasi A; Baigude H
Int J Biol Macromol; 2019 Apr; 126():633-640. PubMed ID: 30572048
[TBL] [Abstract][Full Text] [Related]
19. Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes.
Lu S; Morris VB; Labhasetwar V
Mol Pharm; 2015 Feb; 12(2):621-9. PubMed ID: 25591125
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
